Sentences with phrase «comments on biotechnology»
Avigen, Inc. (NASDAQ: AVGN) «s management has filed its comments on Biotechnology Value Fund (BVF)'s proposal to replace AVGN's board with BVF's slate of director nominees who will support MediciNova, Inc.'s (NASDAQ: MNOV) offer for AVGN.
https://greenbackd.com/
Avigen, Inc. (NASDAQ: AVGN)'s management has filed its comments on Biotechnology Value Fund (BVF)'s proposal to replace AVGN's board with BVF's slate of director nominees who will suppor...
Not exact matches
Commenting on the survey results, David Lipman, director of the US National Center for Biotechnology Information in Bethesda, Maryland, says that the worries about data handling and analysis were an issue even in the earliest discussions of the genome project.
Results: A Research Focus article commenting on recently published nanobiotechnology work at Pacific Northwest National Laboratory appears in the May 2007 issue of the journal Trends in Biotechnology.
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged AVGN, Biotechnology Value Fund on December 1, 2008 2 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Greenbackd Portfolio, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 12, 2009 3 Comments»
Posted in Activist Investors, Biotechnology Value Fund, Highland Capital Management, Millennium Technology Value Partners, Net Cash Stocks, Neurobiological Technologies Inc (NASDAQ: NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Highland Capital Management, Liquidating Value, Millennium Technology Value Partners, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ: NTII) on February 23, 2009 5 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on December 23, 2008 2 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on February 10, 2009 1 Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 28, 2009 1 Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 2, 2009 5 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Net Net Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 17, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on February 16, 2009 1 Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 15, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Net Net Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on January 26, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund on March 17, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stock on December 24, 2008 5 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund on January 15, 2009 1 Comment»
Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Liquidating Value, Liquidation Value, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ: NTII) on May 11, 2009 2 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 19, 2009 2 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidating Value, Net Cash Stock on March 27, 2009 3 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value on May 22, 2009 2 Comments»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on August 27, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), MathStar Inc (OTC: MATH), Mill Road Capital, Nery Capital Partners, Salvatore Muoio, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), MathStar Inc (OTC: MATH), Mill Road Capital, S. Muoio & Co, Salvatore Muoio on January 7, 2009 Leave a Comment»
Posted in Activist Investors, Biotechnology Value Fund, Net Cash Stocks, OrthoLogic Corporation (NASDAQ: CAPS), tagged Biotechnology Value Fund, Net Cash Stock, OrthoLogic Corporation (NASDAQ: CAPS) on March 16, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Northstar Neuroscience Inc (NASDAQ: NSTR), Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ: NTII), Northstar Neuroscience Inc (NASDAQ: NSTR), RA Capital Management on March 11, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Greenbackd Portfolio, Liquidation Value, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on July 21, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, Dolphin Limited Partnership, GAMCO, Icagen Inc (NASDAQ: ICGN), Mill Road Capital, Multimedia Games Inc (NASDAQ: MGAM), Nery Capital Partners, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, InFocus Corporation (NASDAQ: INFS), Kona Grill Inc (NASDAQ: KONA), Multimedia Games Inc (NASDAQ: MGAM), Nery Capital Partners on February 10, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ: CRGN), DellaCamera Capital Management on April 13, 2009 Leave a Comment»
Posted in Activist Investors, Avigen (NASDAQ: AVGN), Biotechnology Value Fund, Net Cash Stocks, Stocks, tagged Activist investment, Avigen Inc (NASDAQ: AVGN), Biotechnology Value Fund, Liquidation Value, Net Cash Stock on August 24, 2009 1 Comment»
Posted in Activist Investors, Biotechnology Value Fund, Greenbackd Portfolio, Net Cash Stocks, OrthoLogic Corporation (NASDAQ: CAPS), tagged Biotechnology Value Fund, Net Cash Stock, OrthoLogic Corporation (NASDAQ: CAPS) on February 27, 2009 2 Comments»
Commenting in an interview with Hays on the challenge of recruiting candidates with the necessary mix of skills to work in this breakthrough area, Riley Doyle of Desktop Genetics, a biotechnology company based in London, said: